 |
(R)-Azasetron besylate |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of platinum-induced ototoxicity in pediatric patients |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-16 00:00:00 |
| Sponsor | Sensorion SA;375, rue du Professeur Joseph Blayac;Montpellier |
